Your session is about to expire
← Back to Search
Behavioural Intervention
Osteopathic Manipulative Treatment for Immune Boosting in Healthy Adults
N/A
Waitlist Available
Led By Brian Loveless, DO
Research Sponsored by Western University of Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Individuals must be 18 years or older
Individuals must be healthy with a BMI under 30, with no primary or secondary immune deficiency or autoimmune disease, and must not be immunocompromised
Must not have
Individuals with a BMI over 30, or with primary or secondary immune deficiency or autoimmune disease, or are immunocompromised
Individuals who cannot tolerate 12 minutes of moderate physical activity
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 5 minutes post-intervention to 4 hours post-intervention.
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if osteopathic manipulative treatment (OMT) can boost the immune system in healthy adults compared to a fake light treatment or exercise. They will measure immune cells and signaling molecules
Who is the study for?
This trial is for healthy adults interested in how different treatments might affect their immune system. Participants will be involved in three separate sessions, each including a unique treatment: osteopathic manipulative treatment (OMT), sham light touch, or exercise. They must complete a physical activity survey and agree to blood draws during visits.
What is being tested?
The study tests the impact of OMT on immune readiness compared to exercise and sham light touch by measuring changes in blood cells and immune signals at multiple times after these treatments. Each participant experiences all three interventions across three visits.
What are the potential side effects?
Since this trial involves non-invasive procedures like OMT, sham light touch, and mild exercise with healthy individuals, significant side effects are not anticipated. However, minor discomfort from the blood draws may occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am healthy, my BMI is under 30, and I do not have immune or autoimmune conditions.
Select...
I haven't had infections or vaccinations in the last 6 weeks.
Select...
I can do moderate exercise for 12 minutes.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a BMI over 30, or an immune system condition.
Select...
I cannot do moderate exercise for 12 minutes.
Select...
I am under 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 5 minutes post-intervention to 4 hours post-intervention.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 5 minutes post-intervention to 4 hours post-intervention.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Complete Blood Count (CBC) with differential
Secondary study objectives
Evaluation of safety based on reported adverse events
Pro-Inflammatory cytokine profiling
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Order 3 - Day 0: Exercise, Week 3: OMT, Week 6: ShamExperimental Treatment3 Interventions
Exercise protocol
followed by a 3-week washout period and then:
Osteopathic Manipulative Treatment (OMT)
followed by a 3-week washout period and then:
Sham protocol.
Group II: Order 2 - Day 0: Sham, Week 3: OMT, Week 6: ExerciseExperimental Treatment3 Interventions
Sham protocol
followed by a 3-week washout period and then:
Osteopathic Manipulative Treatment (OMT)
followed by a 3-week washout period and then:
Exercise protocol.
Group III: Order 1 - Day 0: OMT, Week 3: Sham, Week 6: ExerciseExperimental Treatment3 Interventions
Osteopathic Manipulative Treatment (OMT)
followed by a 3-week washout period and then:
Sham protocol
followed by a 3-week washout period and then:
Exercise protocol.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Osteopathic Manipulative Treatment (OMT)
2021
Completed Phase 4
~400
Find a Location
Who is running the clinical trial?
Western University of Health SciencesLead Sponsor
24 Previous Clinical Trials
1,299 Total Patients Enrolled
American Osteopathic FoundationUNKNOWN
2 Previous Clinical Trials
112 Total Patients Enrolled
Brian Loveless, DOPrincipal InvestigatorProfessor of NMM/OMM and Chief Medical Officer of WesternU Health